title: Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
authors.affiliation: Hacettepe University School of Medicine, Department of Cardiology, 06100 Ankara, Turkey. Electronic address: ghcayildiz@yahoo.com.
authors.forename: Ali
authors.initials: A
authors.lastname: Yildiz
authors.affiliation: Hacettepe University School of Medicine, Department of Cardiology, 06100 Ankara, Turkey.
authors.forename: Serdar
authors.initials: S
authors.lastname: Soydinc
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004077:Digoxin / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000401:mortality*; D006801:Humans; D008297:Male; D018570:Risk Assessment; D020521:Stroke / Q000401:mortality*
chemical_list: D000925:Anticoagulants; D004077:Digoxin
keywords: Atrial fibrillation; Cardiovascular mortality; Digoxin; Heart failure; Mortality